-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Depreciation history and growth rate from 2013 to 2023.
- Elite Pharmaceuticals Inc /Nv/ Depreciation for the quarter ending December 31, 2024 was $313K, a 7% decline year-over-year.
- Elite Pharmaceuticals Inc /Nv/ Depreciation for the twelve months ending December 31, 2024 was $1.19M, a 8.85% decline year-over-year.
- Elite Pharmaceuticals Inc /Nv/ annual Depreciation for 2023 was $1.32M, a 6.69% increase from 2022.
- Elite Pharmaceuticals Inc /Nv/ annual Depreciation for 2022 was $1.24M, a 3.58% increase from 2021.
- Elite Pharmaceuticals Inc /Nv/ annual Depreciation for 2021 was $1.19M, a 8.06% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)